Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1499-1515

  Su, Chia Wei ^a   Chiang, Chih Sheng ^a   Li, Wei Ming ^a   Hu, Shang Hsiu ^b   Chen, San Yuan ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

combination therapy; controlled drug release; imaging; nanocarrier; stimuli sensitive; targeting

Indexed keywords

6 CARBOXYFLUORESCEIN; ANTINEOPLASTIC AGENT; APTAMER; BOVINE SERUM ALBUMIN; CAMPTOTHECIN; CARBOPLATIN; COMBRETASTATIN A4; DOXORUBICIN; FLUORESCEIN; FOLIC ACID; IBUPROFEN; INDOMETACIN; INORGANIC COMPOUND; IRINOTECAN; LAPATINIB; LIPOSOME; NANOCARRIER; NANOMATERIAL; PACLITAXEL; PEPTIDE YY [3-36]; PLASMID DNA; POLYMERSOME; PYRENE; RAPAMYCIN; RHODAMINE B; SMALL INTERFERING RNA; SURAMIN; TARIQUIDAR; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; NANOCAPSULE;

CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CLINICAL PROTOCOL; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; INTRACELLULAR SIGNALING; MICELLE; MULTIDRUG RESISTANCE; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; DIFFUSION; DRUG FORMULATION; NEOPLASMS; PARTICLE SIZE; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIFFUSION; DRUG COMPOUNDING; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOCAPSULES; NEOPLASMS; PARTICLE SIZE;

EID: 84907458579     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.97     Document Type: Review

References (117)

1. Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov. Today 17(17-18), 1044-1052 (2012).
2. Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv. Drug Del. Rev. 61(13), 1203-1213 (2009).
3. Jin C, Li H, He Y, et al. Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo. J. Cancer Res. Clin. Oncol. 136(2), 267-274 (2010).
4. Berhoune M, Banu E, Scotte F, Prognon P, Oudard S, Bonan B. Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Ann. Pharmacother. 42(11), 1640-1652 (2008).
5. Chen Z. Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol. Med. 16(12), 594-602 (2010).
6. Patel NR, Pattni BS, Abouzeid AH, Torchilin VP. Nanopreparations to overcome multidrug resistance in cancer. Adv. Drug Del. Rev. 65(13-14), 1748-1762 (2013).
7. Zhou Y, Yang J, Rhim JS, Kopeek J. HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects. J. Control. Release 172(3), 946-953 (2013).
8. Danquah MK, Zhang XA, Mahato RI. Extravasation of polymeric nanomedicines across tumor vasculature. Adv. Drug Del. Rev. 63(8), 623-639 (2011).
9. Nazir S, Hussain T, Ayub A, Rashid U, Macrobert AJ. Nanomaterials in combating cancer: therapeutic applications and developments. Nanomedicine 10(1), 19-34 (2014).
10. Delcea M, Moehwald H, Skirtach AG. Stimuli-responsive LbL capsules and nanoshells for drug delivery. Adv. Drug Del. Rev. 63(9), 730-747 (2011).
11. Meng F, Zhong Z, Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 10(2), 197-209 (2009).
12. Branco MC, Schneider JP. Self-assembling materials for therapeutic delivery. Acta Biomater. 5(3), 817-831 (2009).
13. Eldar-Boock A, Polyak D, Scomparin A, Satchi-Fainaro R. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. Curr. Opin. Biotechnol. 24(4), 682-689 (2013).
14. Ma P, Mumper RJ. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review. Nano Today 8(3), 313-331 (2013).
15. Creixell M, Peppas NA. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance. Nano Today 7(4), 367-379 (2012).
16. Van Dongen SFM, De Hoog H-PM, Peters RJRW, Nallani M, Nolte RJM, Van Hest JCM. Biohybrid polymer capsules. Chem. Rev. 109(11), 6212-6274 (2009).
17. Landfester K, Musyanovych A, Mailaender V. From polymeric particles to multifunctional nanocapsules for biomedical applications using the miniemulsion process. J. Polymer Sci. 48(3), 493-515 (2010).
18. Duncan R. Polymer therapeutics as nanomedicines: new perspectives. Curr. Opin. Biotechnol. 22(4), 492-501 (2011).
19. Duncan R, Vicent MJ. Polymer therapeutics-prospects for 21st century: the end of the beginning. Adv. Drug Del. Rev. 65(1), 60-70 (2013).
20. Barreto JA, Omalley W, Kubeil M, Graham B, Stephan H, Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv. Mater. 23(12), H18-H40 (2011).
21. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 8(2), 147-166 (2012).
22. Xiong Y, Liu ZZ, Georgieva R, et al. Nonvasoconstrictive hemoglobin particles as oxygen carriers. ACS Nano 7(9), 7454-7461 (2013).
23. Delcea M, Sternberg N, Yashchenok AM, et al. Nanoplasmonics for dual-molecule release through nanopores in the membrane of red blood cells. ACS Nano 6(5), 4169-4180 (2012).
24. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 26(5), 1025-1058 (2009).
25. Patel NR, Rathi A, Mongayt D, Torchilin VP. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. Int. J. Pharm. 416(1), 296-299 (2011).
26. Dai WB, Jin W, Zhang JL, et al. Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by Octreotide-modified stealth liposomes. Pharm. Res. 29(10), 2902-2911 (2012).
27. Zhang YF, Wang JC, Bian DY, Zhang X, Zhang Q. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies. Eur. J. Pharm. Biopharm. 74(3), 467-473 (2010).
28. Ding XW, Cai KY, Luo Z, Li JH, Hu Y, Shen XK. Biocompatible magnetic liposomes for temperature triggered drug delivery. Nanoscale 4(20), 6289-6292 (2012).
29. Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE. Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J. Control. Release 116(2), 150-158 (2006).
30. Pramod PS, Takamura K, Chaphekar S, Balasubramanian N, Jayakannan M. Dextran vesicular carriers for dual encapsulation of hydrophilic and hydrophobic molecules and delivery into cells. Biomacromolecules 13(11), 3627-3640 (2012).
31. Ahmed F, Pakunlu RI, Srinivas G, et al. Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol. Pharm. 3(3), 340-350 (2006).
32. Bae KH, Lee JY, Lee SH, Park TG, Nam YS. Optically traceable solid lipid nanoparticles loaded with siRNA and Paclitaxel for synergistic chemotherapy with in situ imaging. Adv. Healthcare Mat. 2(4), 576-584 (2013).
33. Sun T-M, Du J-Z, Yao Y-D, et al. Simultaneous delivery of siRNA and Paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. ACS Nano 5(2), 1483-1494 (2011).
34. Hu SH, Chen SY, Gao SH.Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand release. ACS Nano 6(3), 2558-2565 (2012).
35. Vergara D, Bellomo C, Zhang XC, et al. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomedicine 8(6), 891-899 (2012).
36. Shutao G, Yong Q, Weiwei W, et al. Poly(epsilon-caprolactone)-graft-poly(2-(N, N-dimethylamino) ethyl methacrylate) nanoparticles: pH dependent thermo-sensitive multifunctional carriers for gene and drug delivery. J. Mater. Chem. 20(33), 6935-6941 (2010).
37. Liu Q, Zhang J, Sun W, Xie QR, Xia W, Gu H. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int. J. Nanomedicine 7, 999-1013 (2012).
38. Liu D, Bimbo LM, Makila E, et al. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. J. Control. Release 170(2), 268-278 (2013).
39. Botao S, Chengtie W, Jiang C. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. Acta Biomater. 8(5), 1901-1907 (2012).
40. Veeranarayanan S, Poulose AC, Mohamed MS, et al. Synergistic targeting of cancer and associated angiogenesis using triple-targeted dual-drug silica nanoformulations for theragnostics. Small 8(22), 3476-3489 (2012).
41. Cui Y, Xu Q, Chow PKH, Wang D, Wang CH. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34(33), 8511-8520 (2013).
42. Zhao XY, Zhu YJ, Chen F, Wu J. Calcium phosphate nanocarriers dual-loaded with bovine serum albumin and ibuprofen: facile synthesis, sequential drug loading and sustained drug release. Chem. Asian J. 7(7), 1610-1615 (2012).
43. Huang S-L. Liposomes in ultrasonic drug and gene delivery. Adv. Drug Del. Rev. 60(10), 1167-1176 (2008).
44. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 60(5), 1197-1201 (2000).
45. Auguste DT, Furman K, Wong A, et al. Triggered release of siRNA from poly(ethylene glycol)-protected, pH-dependent liposomes. J. Control. Release 130(3), 266-274 (2008).
46. Gasselhuber A DM, Rattay F, Wood Bj, Haemmerich D. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PLoS ONE 7(10), (2012).
47. Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Control. Release 142(1), 108-121 (2010).
48. Sirsi SR, Borden MA. State-of-the-art materials for ultrasound-triggered drug delivery. Adv. Drug Del. Rev. 72, 3-14 (2014).
49. Marguet M, Edembe L, Lecommandoux S. Polymersomes in polymersomes: multiple loading and permeability control. Angew. Chem. Int. Ed. 51(5), 1173-1176 (2012).
50. Shi JJ, Xiao ZY, Votruba AR, Vilos C, Farokhzad OC. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angew. Chem. Int. Ed. 50(31), 7027-7031 (2011).
51. Hu SH, Hsieh TY, Chiang CS, et al. Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery. Adv. Healthcare Mat. 3(2), 273-282 (2014).
52. Hai W, Ying Z, Yan W, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32(32), 8281-8290 (2011).
53. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6(6), 714-729 (2010).
54. Kadam Y, Yerramilli U, Bahadur A, Bahadur P. Micelles from PEO-PPO-PEO block copolymers as nanocontainers for solubilization of a poorly water soluble drug hydrochlorothiazide. Coll. Surf. B. Bioint. 83(1), 49-57 (2011).
55. Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials 32(8), 2222-2232 (2011).
56. Mi Y, Zhao J, Feng S-S. Vitamin E. TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int. J. Pharm. 438(1-2), 98-106 (2012).
57. Tang R, Ji W, Panus D, Palumbo RN, Wang C. Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells. J. Control. Release 151(1), 18-27 (2011).
58. Song Z, Feng R, Sun M, et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J. Colloid Interface Sci. 354(1), 116-123 (2011).
59. Xiao H, Song H, Yang Q, et al. A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance. Biomaterials 33(27), 6507-6519 (2012).
60. De Villiers MM, Otto DP, Strydom SJ, Lvov YM. Introduction to nanocoatings produced by layer-by-layer (LbL) self-assembly. Adv. Drug Del. Rev. 63(9), 701-715 (2011).
61. Ai H. Layer-by-layer capsules for magnetic resonance imaging and drug delivery. Adv. Drug Del. Rev. 63(9), 772-788 (2011).
62. Sivakumar S, Bansal V, Cortez C, Chong SF, Zelikin AN, Caruso F. Degradable, surfactant-free, monodisperse polymer-encapsulated emulsions as anticancer drug carriers. Adv. Mater. 21(18), 1820-1824 (2009).
63. Xiong R, Soenen SJ, Braeckmans K, Skirtach AG. Towards theranostic multicompartment microcapsules: in-situ diagnostics and laser-induced treatment. Theranostics 3(3), 141-151 2013).
64. Becker AL, Johnston APR, Caruso F. Layer-by-layer-assembled capsules and films for therapeutic delivery. Small 6(17), 1836-1852 (2010).
65. Po-Jung C, Shang-Hsiu H, Wen-Ting H, San-Yuan C, Dean-Mo L. Geometrical confinement of quantum dots in porous nanobeads with ultraefficient fluorescence for cell-specific targeting and bioimaging. J. Mater. Chem. 22(19), 9568-9575 (2012).
66. Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 10(5), 389-397 (2011).
67. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 29(29), 4012-4021 (2008).
68. Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew. Chem. Int. Ed. 41(17), 3130-3146 (2002).
69. Schmidt HT, Gray BL, Wingert PA, Ostafin AE. Assembly of aqueous-cored calcium phosphate nanoparticles for drug delivery. Chem. Mater. 16(24), 4942-4947 (2004).
70. Sanvicens N, Marco MP. Multifunctional nanoparticles -properties and prospects for their use in human medicine. Trends Biotechnol. 26(8), 425-433 (2008).
71. Yang J, Lee CH, Ko HJ, et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew. Chem. Int. Ed. 46(46), 8836-8839 (2007).
72. Xiong R, Soenen SJ, Braeckmans K, Skirtach AG. Towards theranostic multicompartment microcapsules: in-situ diagnostics and laser-induced treatment. Theranostics 3(3), 141-151 (2013).
73. Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41(7), 2656-2672 (2012).
74. Desale SS, Cohen SM, Zhao Y, Kabanov AV, Bronich TK. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J. Control. Release 171(3), 339-348 (2013).
75. Duan XP, Xiao JS, Yin Q, et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7(7), 5858-5869 (2013).
76. Xiao HH, Li WL, Qi RG, et al. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy. J. Control. Release 163(3), 304-314 (2012).
77. Hu QL, Li W, Hu XR, et al. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. Biomaterials 33(27), 6580-6591 (2012).
78. Mi Y, Zhao J, Feng SS. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. J. Control. Release 169(3), 185-192 (2013).
79. Schleich N, Sibret P, Danhier P, et al. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. Int. J. Pharm. 447(1-2), 94-101 (2013).
80. Hu SH, Liao BJ, Chiang CS, Chen PJ, Chen IW, Chen SY. Core-Shell nanocapsules stabilized by single-component polymer and nanoparticles for magneto-chemotherapy/hyperthermia with multiple drugs. Adv. Mater. 24(27), 3627-3632 (2012).
81. Chiang CS, Hu SH, Liao BJ, Chang YC, Chen SY. Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds. Nanomedicine 10(1), 99-107 (2014).
82. Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, Sahoo SK. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer Therapy. ACS Appl. Mater. Interfaces 3(3), 842-856 (2011).
83. Wadajkar AS, Bhavsar Z, Ko CY, et al. Multifunctional particles for melanoma-targeted drug delivery. Acta Biomater. 8(8), 2996-3004 (2012).
84. Chih-Jen W, Sung CT, Aljuffali IA, Yu-Jie H, Jia-You F. Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomes. Nanotechnology 24(32), 325101 (2013).
85. Wu YL, Yin H, Zhao F, Li J. Multifunctional hybrid nanocarriers consisting of supramolecular polymers and quantum dots for simultaneous dual therapeutics delivery and cellular imaging. Adv. Healthcare Mat. 2(2), 297-301 (2013).
86. Chen Y, Gao Y, Chen H, et al. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-silica chemistry for efficient delivery/co-delivery of hydrophobic agents. Adv. Funct. Mater. 22(8), 1586-1597 (2012).
87. Duong HHP, Yung LYL. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment. Int. J. Pharm. 454(1), 486-495 (2013).
88. Wang F, Zhang D, Zhang Q, et al. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Biomaterials 32(35), 9444-9456 (2011).
89. Zhang L, Radovic-Moreno AF, Alexis F, et al. Co-Delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem 2(9), 1268-1271 (2007).
90. Kolishetti N, Dhar S, Valencia PM, et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc. Natl Acad. Sci. USA, 107(42), 17939-17944 (2010).
91. Yang T, Wang Y, Li Z, et al. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature. Nanomedicine 8(1), 81-92 (2012).
92. Sun X, Pang Z, Ye H, et al. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Biomaterials 33(3), 916-924 (2012).
93. Fokong S, Theek B, Wu Z, et al. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. J. Control. Release 163(1), 75-81 (2012).
94. Meng FH, Zhong ZY, Feijen J. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules 10(2), 197-209 (2009).
95. Li WM, Chen SY, Liu DM. In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging. Acta Biomater. 9(2), 5360-5368 (2013).
96. Dilnawaz F, Singh A, Mohanty C, Sahoo SK. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31(13), 3694-3706 (2010).
97. Song J, Pu L, Zhou J, Duan B, Duan H. Biodegradable theranostic plasmonic vesicles of amphiphilic gold nanorods. ACS Nano 7(11), 9947-9960 (2013).
98. Wu C-H, Cao C, Kim JH, et al. Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett. 12(11), 5475-5480 (2012).
99. Srinivas M, Aarntzen EHJG, Bulte JWM, et al. Imaging of cellular therapies. Adv. Drug Del. Rev. 62(11), 1080-1093 (2010).
100. Rapoport N, Nam KH, Gupta R, et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J. Control. Release 153(1), 4-15 (2011).
101. Licha K, Olbrich C. Optical imaging in drug discovery and diagnostic applications. Adv. Drug Del. Rev. 57(8), 1087-1108 (2005).
102. Sutton EJ, Henning TD, Pichler BJ, Bremer C, Daldrup-Link HE. Cell tracking with optical imaging. Eur. Radiol. 18(10), 2021-2032 (2008).
103. Probst CE, Zrazhevskiy P, Bagalkot V, Gao X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv. Drug Del. Rev. 65(5), 703-718 (2013).
104. Susumu K, Oh E, Delehanty JB, et al. Multifunctional compact zwitterionic ligands for preparing robust biocompatible semiconductor quantum dots and gold nanoparticles. J. Am. Chem. Soc. 133(24), 9480-9496 (2011).
105. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Del. Rev. 37(1-3), 139-157 (1999).
106. Ferrara KW, Borden MA, Zhang H. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. Acc. Chem. Res. 42(7), 881-892 (2009).
107. Huang H-Y, Hu S-H, Hung S-Y, et al. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy. J. Control. Release 172(1), 118-127 (2013).
108. Peer D, Karp, Jeffrey M, et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nano. 2(12), 751-760 (2007).
109. Morachis JM, Mahmoud EA, Almutairi A. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol. Rev. 64(3), 505-519 (2012).
110. Yu Mk PJ, Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2(1), 3-42 (2012).
111. Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur. J. Pharm. Sci. 48(3), 416-427 (2013).
112. Mukherji SK. Bevacizumab (Avastin). Am. J. Neuroradiol. 31(2), 235-236 (2010).
113. Vincenzi B, Santini D, Tonini G. New issues on Cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor. J. Clin. Oncol. 24(12), 1957 (2006).
114. Weiner GJ. Rituximab: mechanism of action. Semin. Hematol. 47(2), 115-123 (2010).
115. Xiao Z, Farokhzad OC. Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities. ACS Nano 6(5), 3670-3676 (2012).
116. Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9(7), 537-550 (2010).
117. Shao K, Huang R, Li J, et al. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. J. Control. Release 147(1), 118-126 (2010).